...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: ZEN-3694 mCRPC Trial Status
6
Oct 24, 2017 11:18AM
1
Oct 25, 2017 09:02AM

Nextblockbuster

Yep, this has the potential to yield SanFran's Star Factories each being sold or licensed (possibly numerous regions and/or companies). Even with just a few "Stars" this could generate huge revenue. With a current set of 1500 compounds there potentially could be many stars.

Zenith shareholders (of which there were 125,207,692 shares issued) own a private company called Zenith Capital which owns the royalty preferred shares of RVX and it owns 100% of Zenith Epigenetics. I haven't checked the shareholder structure lately but I believe Eastern is dominant by far and Don has management control at this stage.

The question I possed before, and I'd like to hear from experts on this, is how will share holders ever receive a payout on their shares. For example, let's say ZenEpi sells a "Star" and generates $2,000,000,000 as an example. This money could stay within ZenEpi or it could flow to ZCC to fund acquisitions and other trials, etc. Either way the money sits in 1 of 2 private companies. So what are the options for me to get money for my shares?

  1. ZCC or ZE could decide to pay a dividend. That would be a decision by Don and the BOD.
  2. Perhaps any "Star" could be spun out into a public company?
  3. If Eastern sees a multibillion dollar company perhaps they'd buy us out?

Anyway, this is not at all clear to me. I sure like to hear some POVs because I know from the past 9 years Don is not going to treat shareholders like me very well at all.

GLTA

Toinv

 

5
Oct 26, 2017 12:13PM

Nov 02, 2017 03:38PM

Nov 02, 2017 04:29PM

Nov 03, 2017 10:49AM

Nov 03, 2017 10:58AM

Nov 03, 2017 12:07PM
2
Nov 03, 2017 03:45PM
2
Nov 03, 2017 04:23PM
5
Nov 18, 2017 07:45PM
Share
New Message
Please login to post a reply